{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:41:22Z","timestamp":1791222082308,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jocn.2021.11.029","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T13:10:28Z","timestamp":1639746628000},"page":"172-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"special_numbering":"C","title":["Idiopathic intracranial hypertension: Pathophysiology, diagnosis and management"],"prefix":"10.1016","volume":"95","author":[{"given":"Michael T.M.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Tariq","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen V.","family":"Danesh-Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.jocn.2021.11.029_b0005","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","article-title":"Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children","volume":"81","author":"Friedman","year":"2013","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jocn.2021.11.029_b0010","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamaneurol.2014.133","article-title":"The idiopathic intracranial hypertension treatment trial: clinical profile at baseline","volume":"71","author":"Wall","year":"2014","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1016\/j.jocn.2021.11.029_b0015","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1001\/jamaneurol.2019.1812","article-title":"Association between Idiopathic Intracranial Hypertension and Risk of Cardiovascular Diseases in Women in the United Kingdom","volume":"76","author":"Adderley","year":"2019","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.jocn.2021.11.029_b0020","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41433-018-0238-5","article-title":"The expanding burden of idiopathic intracranial hypertension","volume":"33","author":"Mollan","year":"2019","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.jocn.2021.11.029_b0025","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ophtha.2017.01.006","article-title":"Re-evaluating the Incidence of Idiopathic Intracranial Hypertension in an Era of Increasing Obesity","volume":"124","author":"Kilgore","year":"2017","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.jocn.2021.11.029_b0030","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/jnnp-2017-317440","article-title":"Idiopathic intracranial hypertension: consensus guidelines on management","volume":"89","author":"Mollan","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"16","key":"10.1016\/j.jocn.2021.11.029_b0035","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.2014.3312","article-title":"Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial","volume":"311","author":"Wall","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jocn.2021.11.029_b0040","doi-asserted-by":"crossref","unstructured":"Sinclair AJ, Burdon MA, Nightingale PG, Ball AK, Good P, Matthews TD, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. Bmj. 2010;341:c2701.","DOI":"10.1136\/bmj.c2701"},{"issue":"2","key":"10.1016\/j.jocn.2021.11.029_b0045","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s10143-020-01288-1","article-title":"A systematic review of surgical treatments of idiopathic intracranial hypertension (IIH)","volume":"44","author":"Kalyvas","year":"2021","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.jocn.2021.11.029_b0050","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s004150070182","article-title":"Incidence of idiopathic intracranial hypertension in Hokkaido, the northernmost island of Japan","volume":"247","author":"Yabe","year":"2000","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.jocn.2021.11.029_b0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/112067210401400108","article-title":"Idiopathic intracranial hypertension (pseudotumor cerebri): descriptive epidemiology, clinical features, and visual outcome in Parma, Italy, 1990 to 1999","volume":"14","author":"Carta","year":"2004","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jocn.2021.11.029_b0060","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nrl.2013.08.009","article-title":"Idiopathic intracranial hypertension: descriptive analysis in our setting","volume":"30","author":"Contreras-Martin","year":"2015","journal-title":"Neurologia"},{"issue":"1","key":"10.1016\/j.jocn.2021.11.029_b0065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000435919","article-title":"Idiopathic Intracranial Hypertension in the Northwest of Northern Ireland: Epidemiology and Clinical Management","volume":"45","author":"McCluskey","year":"2015","journal-title":"Neuroepidemiology"},{"issue":"Suppl 1","key":"10.1016\/j.jocn.2021.11.029_b0070","doi-asserted-by":"crossref","first-page":"A6.1","DOI":"10.1136\/archdischild-2012-301885.14","article-title":"UK surveillance of childhood idiopathic intracranial hypertension (IIH)","volume":"97","author":"Matthews","year":"2012","journal-title":"Arch Dis Child"},{"issue":"8","key":"10.1016\/j.jocn.2021.11.029_b0075","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/ene.12442","article-title":"The incidence of idiopathic intracranial hypertension in Israel from 2005 to 2007: results of a nationwide survey","volume":"21","author":"Kesler","year":"2014","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.jocn.2021.11.029_b0080","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ajo.2006.12.040","article-title":"Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri)","volume":"143","author":"Daniels","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jocn.2021.11.029_b0085","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jpeds.2013.01.048","article-title":"Pediatric idiopathic intracranial hypertension and extreme childhood obesity: a role for weight gain","volume":"162","author":"Salpietro","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.jocn.2021.11.029_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.6064\/2012\/708042","article-title":"The prevalence of polycystic ovary syndrome in women with idiopathic intracranial hypertension","volume":"2012","author":"Avisar","year":"2012","journal-title":"Scientifica (Cairo)"},{"issue":"7","key":"10.1016\/j.jocn.2021.11.029_b0095","doi-asserted-by":"crossref","first-page":"e921","DOI":"10.1212\/WNL.0000000000009312","article-title":"Mortality among patients with idiopathic intracranial hypertension enrolled in the IH Registry","volume":"95","author":"Hermes","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2021.11.029_b0100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12987-019-0129-6","article-title":"Cerebrospinal fluid dynamics and intracranial pressure elevation in neurological diseases","volume":"16","author":"Bothwell","year":"2019","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"10.1016\/j.jocn.2021.11.029_b0105","doi-asserted-by":"crossref","DOI":"10.1186\/2045-8118-11-12","article-title":"Cerebrospinal fluid is drained primarily via the spinal canal and olfactory route in young and aged spontaneously hypertensive rats","volume":"11","author":"Murtha","year":"2014","journal-title":"Fluids Barriers CNS"},{"issue":"3","key":"10.1016\/j.jocn.2021.11.029_b0110","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1113\/JP275105","article-title":"Intrathecal antibody distribution in the rat brain: surface diffusion, perivascular transport and osmotic enhancement of delivery","volume":"596","author":"Pizzo","year":"2018","journal-title":"J Physiol"},{"issue":"4","key":"10.1016\/j.jocn.2021.11.029_b0115","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1212\/WNL.42.4.851","article-title":"CSF hydrodynamics in idiopathic intracranial hypertension: a long-term study","volume":"42","author":"Malm","year":"1992","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jocn.2021.11.029_b0120","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/BF00612116","article-title":"Assessment of CSF dynamics and venous flow in the superior sagittal sinus by MRI in idiopathic intracranial hypertension: a preliminary study","volume":"36","author":"Gideon","year":"1994","journal-title":"Neuroradiology"},{"issue":"3","key":"10.1016\/j.jocn.2021.11.029_b0125","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/brain\/83.3.454","article-title":"The cerebrospinal fluid valves","volume":"83","author":"Welch","year":"1960","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2021.11.029_b0130","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3171\/2017.8.JNS17459","article-title":"Fifty shades of gradients: does the pressure gradient in venous sinus stenting for idiopathic intracranial hypertension matter? A systematic review","volume":"130","author":"McDougall","year":"2018","journal-title":"J Neurosurg"},{"issue":"2","key":"10.1016\/j.jocn.2021.11.029_b0135","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2214\/AJR.12.9638","article-title":"Association of MRI findings and visual outcome in idiopathic intracranial hypertension","volume":"201","author":"Saindane","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jocn.2021.11.029_b0140","doi-asserted-by":"crossref","unstructured":"Ball AK, Sinclair AJ, Curnow SJ, Tomlinson JW, Burdon MA, Walker EA, et al. Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance? Clin Endocrinol (Oxf). 2009;70:863-9.","DOI":"10.1111\/j.1365-2265.2008.03401.x"},{"issue":"13","key":"10.1016\/j.jocn.2021.11.029_b0145","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/0333102415570762","article-title":"Oligoclonal bands and increased cytokine levels in idiopathic intracranial hypertension","volume":"35","author":"Alt\u0131okka-Uzun","year":"2015","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jocn.2021.11.029_b0150","doi-asserted-by":"crossref","unstructured":"O'Reilly MW, Westgate CS, Hornby C, Botfield H, Taylor AE, Markey K, et al. A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. JCI Insight. 2019;4.","DOI":"10.1172\/jci.insight.125348"},{"issue":"12","key":"10.1016\/j.jocn.2021.11.029_b0155","doi-asserted-by":"crossref","first-page":"e1.46","DOI":"10.1136\/jnnp-2016-315106.14","article-title":"The andro-metabolic signature of IIH compared with PCOS and simple obesity","volume":"87","author":"Hornby","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/j.jocn.2021.11.029_b0160","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3109\/02713683.2013.799214","article-title":"Hyperandrogenism is associated with earlier age of onset of idiopathic intracranial hypertension in women","volume":"38","author":"Klein","year":"2013","journal-title":"Curr Eye Res"},{"issue":"404","key":"10.1016\/j.jocn.2021.11.029_b0165","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0972","article-title":"A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus","volume":"9","author":"Botfield","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jocn.2021.11.029_b0170","unstructured":"ISRCTN registry [Internet]. London: BMC. Identifier ISRCTN12678718, IIH Pressure - a new treatment for raised brain pressure in Idiopathic Intracranial Hypertension; Aug 11, 2017 [cited Oct 4, 2020 ]; Available from: http:\/\/www.isrctn.com\/ISRCTN12678718."},{"key":"10.1016\/j.jocn.2021.11.029_b0175","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1210\/jc.2010-0729","article-title":"Cerebrospinal fluid corticosteroid levels and cortisol metabolism in patients with idiopathic intracranial hypertension: a link between 11beta-HSD1 and intracranial pressure regulation?","volume":"95","author":"Sinclair","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocn.2021.11.029_b0180","doi-asserted-by":"crossref","unstructured":"Markey K, Mitchell J, Botfield H, Ottridge RS, Matthews T, Krishnan A, et al. 11\u03b2-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial. Brain Communications. 2020;2.","DOI":"10.1093\/braincomms\/fcz050"},{"issue":"1","key":"10.1016\/j.jocn.2021.11.029_b0185","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0014-2999(78)90035-3","article-title":"Angiotensin-converting enzyme: presence of high activity in choroid plexus of mammalian brain","volume":"52","author":"Arregui","year":"1978","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.jocn.2021.11.029_b0190","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/0333102410375726","article-title":"Cerebrospinal fluid markers of idiopathic intracranial hypertension: is the renin-angiotensinogen system involved?","volume":"31","author":"Brettschneider","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jocn.2021.11.029_b0195","doi-asserted-by":"crossref","unstructured":"Kuehn MH, Mishra R, Deonovic BE, Miller KN, McCormack SE, Liu GT, et al. Genetic Survey of Adult-Onset Idiopathic Intracranial Hypertension. J Neuroophthalmol. 2019;39:50-5.","DOI":"10.1097\/WNO.0000000000000648"},{"issue":"24","key":"10.1016\/j.jocn.2021.11.029_b0200","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1212\/WNL.0000000000001687","article-title":"Quality of life in idiopathic intracranial hypertension at diagnosis: IIH Treatment Trial results","volume":"84","author":"Digre","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2021.11.029_b0205","first-page":"155","article-title":"Idiopathic intracranial hypertension. A prospective study of 50 patients","volume":"114(Pt 1A)","author":"Wall","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2021.11.029_b0210","first-page":"59","article-title":"Contrast sensitivity, color vision and perimetry in 100 examinations of patients with optic neuropathies and normal Snellen acuity","volume":"43","author":"Wall","year":"1989","journal-title":"Doc Ophthalmol Proc Ser"},{"issue":"1","key":"10.1016\/j.jocn.2021.11.029_b0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp.45.1.13","article-title":"Swelling of the optic nerve head: a staging scheme","volume":"45","author":"Frisen","year":"1982","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.jocn.2021.11.029_b0220","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archneur.1978.00500250041009","article-title":"The Clinical Significance of Spontaneous Pulsations of the Retinal Vein","volume":"35","author":"Levin","year":"1978","journal-title":"Arch Neurol"},{"issue":"S1","key":"10.1016\/j.jocn.2021.11.029_b0225","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10072-013-1373-1","article-title":"Quantitative analysis of optic nerve damage in idiopathic intracranial hypertension (IIH) at diagnosis","volume":"34","author":"Marzoli","year":"2013","journal-title":"Neurol Sci"},{"issue":"12","key":"10.1016\/j.jocn.2021.11.029_b0230","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.ophtha.2017.06.016","article-title":"Accuracy of Diagnostic Imaging Modalities for Classifying Pediatric Eyes as Papilledema Versus Pseudopapilledema","volume":"124","author":"Chang","year":"2017","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.jocn.2021.11.029_b0235","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1167\/iovs.08-2528","article-title":"Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography","volume":"50","author":"Rebolleda","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jocn.2021.11.029_b0240","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ajo.2016.12.017","article-title":"The Effect of Treatment of Idiopathic Intracranial Hypertension on Prevalence of Retinal and Choroidal Folds","volume":"176","author":"Kupersmith","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.jocn.2021.11.029_b0245","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/jamaophthalmol.2020.4242","article-title":"Using Optical Coherence Tomography as a Surrogate of Measurements of Intracranial Pressure in Idiopathic Intracranial Hypertension","volume":"138","author":"Vijay","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.jocn.2021.11.029_b0250","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/ene.13893","article-title":"Optical coherence tomography represents a sensitive and reliable tool for routine monitoring of idiopathic intracranial hypertension with and without papilledema","volume":"26","author":"Huang\u2010Link","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2021.11.029_b0255","doi-asserted-by":"crossref","unstructured":"McHugh JA, D\u2019Antona L, Toma AK, Bremner FD. Spontaneous Venous Pulsations Detected With Infrared Videography. J Neuroophthalmol 2020;40:174-7.","DOI":"10.1097\/WNO.0000000000000815"},{"issue":"9","key":"10.1016\/j.jocn.2021.11.029_b0260","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.ophtha.2009.03.056","article-title":"Functional visual loss in idiopathic intracranial hypertension","volume":"116","author":"Ney","year":"2009","journal-title":"Ophthalmology"},{"issue":"04","key":"10.1016\/j.jocn.2021.11.029_b0265","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1055\/s-0034-1396333","article-title":"Malignant hypertension: clinical manifestations of 7 cases","volume":"232","author":"Steinegger","year":"2015","journal-title":"Klin Monbl Augenheilkd"},{"issue":"6","key":"10.1016\/j.jocn.2021.11.029_b0270","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0008-4182(05)80100-0","article-title":"Frequency and amplitude of elevation of cerebrospinal fluid resting pressure by the Valsalva maneuver","volume":"40","author":"Neville","year":"2005","journal-title":"Can J Ophthalmol"},{"issue":"9","key":"10.1016\/j.jocn.2021.11.029_b0275","doi-asserted-by":"crossref","first-page":"e017426","DOI":"10.1136\/bmjopen-2017-017426","article-title":"Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol","volume":"7","author":"Ottridge","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jocn.2021.11.029_b0280","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0022-3565(25)29822-6","article-title":"The effect of acetazolamide and furosemide on cerebrospinal fluid production and choroid plexus carbonic anhydrase activity","volume":"189","author":"McCarthy","year":"1974","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.jocn.2021.11.029_b0285","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1007\/s00415-010-5861-4","article-title":"A randomised controlled trial of treatment for idiopathic intracranial hypertension","volume":"258","author":"Ball","year":"2011","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.jocn.2021.11.029_b0290","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/088307389400900205","article-title":"Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series","volume":"9","author":"Schoeman","year":"1994","journal-title":"J Child Neurol"},{"issue":"5","key":"10.1016\/j.jocn.2021.11.029_b0295","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-0404.2007.00905.x","article-title":"Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study","volume":"116","author":"\u00c7elebisoy","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jocn.2021.11.029_b0300","article-title":"Octreotide: a therapeutic option for idiopathic intracranial hypertension","volume":"1","author":"Panagopoulos","year":"2007","journal-title":"Neurol Neurophysiol Neurosci."},{"issue":"10","key":"10.1016\/j.jocn.2021.11.029_b0305","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/bjophthalmol-2014-304953","article-title":"Visual outcomes of surgical intervention for pseudotumour cerebri: optic nerve sheath fenestration versus cerebrospinal fluid diversion","volume":"98","author":"Fonseca","year":"2014","journal-title":"Br J Ophthalmol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821005853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821005853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:29:28Z","timestamp":1760822968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586821005853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":61,"alternative-id":["S0967586821005853"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2021.11.029","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Idiopathic intracranial hypertension: Pathophysiology, diagnosis and management","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2021.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}